United States-based Medivant Healthcare has donated 5,000 vials of Lidocaine one percent Single Dose Injectables to Lake Charles Memorial Hospital, it was reported on Monday.
The company has taken this step following the devastation caused by Hurricane Laura. Presently, the product is required to sustain US Hospital Emergency Rooms and ICUs.
Founder of Medivant Healthcare, Viraj Gandhi, said, 'Generic Medicine Made in the USA, For the USA', is not just our slogan, it's what we do on a daily basis. Being located in Arizona, we are able to deliver our generics anywhere in the US, within a day or two. When tragedy hits our nation, such as Covid-19, Natural Disasters and other Perils, we don't just sell, we give. Our hearts go out to those who are suffering from the devastation in Lake Charles, due to Hurricane Laura. We hope our donation makes a difference, helping the hospital, their patients and their families in the community.'
First FDA acceptance to waive clinical efficacy studies for monoclonal antibody biosimilars
Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial
Viatris' generic iron sucrose injection gains US FDA approval
Newbury Pharmaceuticals gains Finnish approval for generic melatonin
CivicaScript to distribute biosimilar for chronic inflammatory conditions
Mallinckrodt and Endo complete merger
Zenara Pharma's Sertraline Hydrochloride Capsules generic receives US FDA approval
EQT agrees to acquire majority stake in Adalvo
Mallinckrodt receives Irish High Court ruling to combine with Endo Inc
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CivicaScript introduces low-cost multiple sclerosis treatment
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment